富士製薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/25 | 1,200 | 1,205 | 1,186 | 1,204 | +15 | +1.3% | 86,700 |
2023/09/22 | 1,186 | 1,194 | 1,182 | 1,189 | -9 | -0.8% | 69,300 |
2023/09/21 | 1,190 | 1,208 | 1,187 | 1,198 | +3 | +0.3% | 54,400 |
2023/09/20 | 1,225 | 1,225 | 1,191 | 1,195 | -24 | -2% | 138,800 |
2023/09/19 | 1,237 | 1,237 | 1,208 | 1,219 | -23 | -1.9% | 162,200 |
2023/09/15 | 1,243 | 1,246 | 1,230 | 1,242 | +3 | +0.2% | 81,100 |
2023/09/14 | 1,232 | 1,242 | 1,232 | 1,239 | +13 | +1.1% | 48,200 |
2023/09/13 | 1,217 | 1,229 | 1,214 | 1,226 | +6 | +0.5% | 36,500 |
2023/09/12 | 1,215 | 1,228 | 1,213 | 1,220 | +12 | +1% | 42,300 |
2023/09/11 | 1,196 | 1,208 | 1,195 | 1,208 | +22 | +1.9% | 40,700 |
2023/09/08 | 1,195 | 1,203 | 1,186 | 1,186 | -8 | -0.7% | 59,100 |
2023/09/07 | 1,195 | 1,196 | 1,184 | 1,194 | -1 | -0.1% | 56,400 |
2023/09/06 | 1,194 | 1,200 | 1,188 | 1,195 | +5 | +0.4% | 67,700 |
2023/09/05 | 1,180 | 1,194 | 1,176 | 1,190 | +11 | +0.9% | 82,000 |
2023/09/04 | 1,180 | 1,183 | 1,175 | 1,179 | +1 | +0.1% | 66,800 |
2023/09/01 | 1,175 | 1,181 | 1,171 | 1,178 | +3 | +0.3% | 40,400 |
2023/08/31 | 1,174 | 1,185 | 1,171 | 1,175 | +1 | +0.1% | 46,400 |
2023/08/30 | 1,180 | 1,182 | 1,168 | 1,174 | -3 | -0.3% | 63,200 |
2023/08/29 | 1,184 | 1,186 | 1,177 | 1,177 | -4 | -0.3% | 56,000 |
2023/08/28 | 1,170 | 1,183 | 1,170 | 1,181 | +21 | +1.8% | 60,700 |
2023/08/25 | 1,159 | 1,169 | 1,155 | 1,160 | ±0 | ±0% | 40,900 |
2023/08/24 | 1,163 | 1,166 | 1,156 | 1,160 | -3 | -0.3% | 23,300 |
2023/08/23 | 1,156 | 1,165 | 1,155 | 1,163 | -6 | -0.5% | 30,200 |
2023/08/22 | 1,160 | 1,169 | 1,151 | 1,169 | +17 | +1.5% | 41,000 |
2023/08/21 | 1,157 | 1,168 | 1,152 | 1,152 | -3 | -0.3% | 34,600 |
2023/08/18 | 1,135 | 1,163 | 1,128 | 1,155 | +17 | +1.5% | 83,000 |
2023/08/17 | 1,161 | 1,161 | 1,126 | 1,138 | -22 | -1.9% | 117,800 |
2023/08/16 | 1,197 | 1,197 | 1,148 | 1,160 | +53 | +4.8% | 354,800 |
2023/08/15 | 1,104 | 1,108 | 1,098 | 1,107 | +3 | +0.3% | 35,500 |
2023/08/14 | 1,110 | 1,118 | 1,096 | 1,104 | +1 | +0.1% | 54,500 |
2023/08/10 | 1,101 | 1,105 | 1,088 | 1,103 | +2 | +0.2% | 89,800 |
2023/08/09 | 1,102 | 1,112 | 1,088 | 1,101 | -71 | -6.1% | 236,800 |
2023/08/08 | 1,170 | 1,176 | 1,165 | 1,172 | +5 | +0.4% | 35,000 |
2023/08/07 | 1,147 | 1,174 | 1,146 | 1,167 | +17 | +1.5% | 48,900 |
2023/08/04 | 1,150 | 1,155 | 1,142 | 1,150 | -4 | -0.3% | 39,300 |
2023/08/03 | 1,175 | 1,175 | 1,153 | 1,154 | -26 | -2.2% | 58,200 |
2023/08/02 | 1,181 | 1,187 | 1,170 | 1,180 | -9 | -0.8% | 68,400 |
2023/08/01 | 1,174 | 1,189 | 1,168 | 1,189 | +21 | +1.8% | 52,900 |
2023/07/31 | 1,180 | 1,186 | 1,164 | 1,168 | -2 | -0.2% | 56,600 |
2023/07/28 | 1,168 | 1,173 | 1,158 | 1,170 | -9 | -0.8% | 59,000 |
2023/07/27 | 1,170 | 1,184 | 1,161 | 1,179 | +4 | +0.3% | 52,900 |
2023/07/26 | 1,170 | 1,180 | 1,162 | 1,175 | +9 | +0.8% | 42,000 |
2023/07/25 | 1,172 | 1,172 | 1,159 | 1,166 | -5 | -0.4% | 59,000 |
2023/07/24 | 1,151 | 1,171 | 1,144 | 1,171 | +31 | +2.7% | 100,600 |
2023/07/21 | 1,133 | 1,143 | 1,128 | 1,140 | +7 | +0.6% | 32,700 |
2023/07/20 | 1,140 | 1,140 | 1,127 | 1,133 | -2 | -0.2% | 33,500 |
2023/07/19 | 1,122 | 1,136 | 1,120 | 1,135 | +23 | +2.1% | 49,300 |
2023/07/18 | 1,110 | 1,120 | 1,110 | 1,112 | +2 | +0.2% | 43,400 |
2023/07/14 | 1,113 | 1,117 | 1,106 | 1,110 | -4 | -0.4% | 29,700 |
2023/07/13 | 1,108 | 1,118 | 1,101 | 1,114 | +4 | +0.4% | 47,000 |
151~
200
件表示中 / 6704件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
富士製薬 | 156,300円 | +19.7% | +23.1% | 2.72% | 6.14倍 | 0.92倍 |
|
女性医療、急性期医療の2領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
生化学 | 74,000円 | +7.9% | -26.7% | 3.51% | 15.53倍 | 0.56倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。2種のヒアルロン酸製剤は科研と参天が販売 |
ダイト | 252,400円 | +5.3% | -7.1% | 2.38% | 11.79倍 | 0.75倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ミズホメディ | 330,500円 | -5.1% | -21.2% | 4.84% | 10.44倍 | 2.01倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
セルソース | 148,900円 | +19.0% | -13.1% | 0.34% | 41.02倍 | 4.80倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム